Invention Grant
- Patent Title: Alpha-hemolysin variants and uses thereof
-
Application No.: US16425743Application Date: 2019-05-29
-
Publication No.: US10968480B2Publication Date: 2021-04-06
- Inventor: Timothy K. Craig , Mark R. Ambroso , Corissa J. Harris , Matthew M. Dipietro , Yaozhong Zou , Marshall W. Porter
- Applicant: Roche Sequencing Solutions, Inc.
- Applicant Address: US CA Pleasanton
- Assignee: Roche Sequencing Solutions, Inc.
- Current Assignee: Roche Sequencing Solutions, Inc.
- Current Assignee Address: US CA Pleasanton
- Agency: FisherBroyles, LLP
- Agent Victoria L. Boyd; Jason M. Pass
- Main IPC: C07K14/31
- IPC: C07K14/31 ; C12Q1/6869 ; C12Q1/689 ; G01N33/487 ; G01N27/447

Abstract:
Described herein are variants of alpha-hemolysin having at least one mutation, such as a mutation to a positive charge. In certain examples, the mutation is selected from V149K, E287R, H35G, T109K, P151K, K147N, E111N, M113A, or combinations thereof in the mature, wild-type alpha-hemolysin amino acid sequence. The α-hemolysin variants may also include a substitution at H144A and/or a series of glycine residues spanning residues 127 to 131 of the mature, wild-type alpha hemolysin. Also provided are nanopore assemblies including the alpha-hemolysin variants, the assembly having a decreased time-to-thread. The decreased time-to-thread, for example, increases DNA sequencing efficiency and accuracy.
Information query